Neuro Spine Mainstay Medical Announces Positive Results from the Landmark ReActiv8® RESTORE Clinical Trial byTim AllenJanuary 16, 2025
Spine Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc® 2-Level IDE clinical trial byJosh SandbergSeptember 25, 2024
Spine Top Stories Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain byJosh SandbergSeptember 24, 2024
Sports Medicine Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi byTim AllenSeptember 17, 2024
Spine Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey byTim AllenAugust 29, 2024
Spine Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans byJosh SandbergAugust 21, 2024
Spine Amber Implants Completes Enrollment of First-In-Human Clinical Trial of its VCFix® Spinal System byJosh SandbergJune 11, 2024
Recon HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery byTim AllenMay 20, 2024
Biologics Spine Bone Biologics Reports Progress With NB1 Clinical Program byJosh SandbergMarch 1, 2024
Financial Spine Top Stories Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership byJosh SandbergFebruary 5, 2024
